三阴性乳腺癌基因组指标与免疫浸润之间的关联
该研究利用癌症基因组图谱(TCGA)乳腺癌数据集(n=1215)中的DNA和RNA测序数据及mRNA表达结果,计算免疫元基因表达值和组织学淋巴细胞计数以量化免疫浸润并对三阴性乳腺癌(TNBC)进行预后分类,并以METABRIC数据集作为独立验证队列。研究纳入193例具有患者生存信息的TNBC样本,发现克隆异质性与免疫元基因表达呈负相关(ρ=-0.395,P=2×10⁻⁸),免疫元基因表达与体细胞拷贝数改变水平呈负相关(ρ=-0.484,P=2×10⁻¹⁰),预后好的淋巴细胞丰富型TNBC的突变和新抗原计数显著低于预后差的淋巴细胞贫乏型TNBC。
要点
- 克隆异质性与免疫元基因表达呈负相关(ρ=-0.395,P=2×10⁻⁸)。
- 免疫元基因表达与体细胞拷贝数改变水平呈负相关(ρ=-0.484,P=2×10⁻¹⁰)。
- 预后好的淋巴细胞丰富型TNBC突变和新抗原计数显著低于预后差的淋巴细胞贫乏型TNBC。
核心结论
- 研究提示免疫丰富的TNBC可能处于持续清除许多免疫原性克隆的免疫监视之下,导致克隆异质性较低。
- 这些癌症也可能代表可从免疫检查点抑制剂治疗中获益的TNBC亚组,使平衡向有利于免疫系统的方向倾斜。
研究设计与样本
- 研究于2015年6月1日至2017年1月31日进行,使用癌症基因组图谱(TCGA)乳腺癌数据集(n=1215)的DNA和RNA测序数据及信使RNA表达结果计算免疫元基因表达值和组织学淋巴细胞计数以量化免疫浸润并对TNBC进行预后分类。
- 使用乳腺癌分子分类国际联盟(METABRIC)数据集作为独立验证队列。
- 比较预后好的免疫丰富TNBC队列与预后差的免疫贫乏TNBC队列之间的克隆异质性、体细胞总突变负荷、新抗原负荷和体细胞拷贝数改变水平,并比较119个经典癌症基因的突变分布。
- 研究纳入193例具有患者生存信息的TNBC样本。
主要发现
- 在193例具有患者生存信息的TNBC样本中,克隆异质性与免疫元基因表达呈负相关(ρ=-0.395,P=2×10⁻⁸)。
- 免疫元基因表达与体细胞拷贝数改变水平呈负相关(ρ=-0.484,P=2×10⁻¹⁰)。
- 预后好的淋巴细胞丰富型TNBC的突变和新抗原计数显著低于预后差的淋巴细胞贫乏型TNBC。
- 在相同TCGA数据集和独立METABRIC数据集中使用不同的免疫元基因确认了研究结果的稳健性。
关键数值与推荐
- 克隆异质性与免疫元基因表达的相关系数ρ=-0.395,P=2×10⁻⁸。
- 免疫元基因表达与体细胞拷贝数改变水平的相关系数ρ=-0.484,P=2×10⁻¹⁰。
- 研究比较了119个经典癌症基因的突变分布。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Why some triple-negative breast cancers (TNBCs) have high and others have low immune cell infiltration is unknown. Understanding how immune surveillance shapes the cancer genome could help in the selection of patients and the development of more effective immunotherapy strategies. OBJECTIVE: To examine the association between genomic metrics and the extent of immune infiltration in TNBCs. DESIGN, SETTING, AND PARTICIPANTS: This study, performed from June 1, 2015, through January 31, 2017, used DNA and RNA sequencing data and messenger RNA expression results from The Cancer Genome Atlas (TCGA) breast cancer data set (n = 1215) to calculate previously described immune metagene expression values and histologic lymphocyte counts to quantify immune infiltration and assign prognostic categories to TNBCs. It used the Molecular Taxonomy of Breast Cancer International Consortium (METABRIC) data set as an independent validation cohort. The study compared clonal heterogeneity, somatic total mutational load, neoantigen load, and somatic copy number alteration levels between immune-rich TNBC cohorts with good prognosis and immune-poor TNBC cohorts with poor prognosis. The study also compared the distribution of mutations in 119 canonical cancer genes. MAIN OUTCOMES AND MEASURES: Correlation between immune prognostic category and genomic metrics of the cancer. RESULTS: This study of 193 TNBC samples with patient survival information found an inverse association between clonal heterogeneity and immune metagene expression (ρ = −0.395, P = 2 × 10−8). The study also found an inverse association between immune metagene expression and somatic copy number alteration levels (ρ = −0.484, P = 2 × 10−10). Lymphocyte-rich TNBCs with good prognosis had significantly lower mutation and neoantigen counts than did lymphocyte-poor TNBCs with poor prognosis. The robustness of the study results was confirmed by using various immune metagenes in the same TCGA data set and in the independent METABRIC data set. CONCLUSIONS AND RELEVANCE: This study suggests that immune-rich TNBCs may be under an immune surveillance that continuously eliminates many immunogenic clones, resulting in lower clonal heterogeneity. These cancers may also represent the subset of TNBCs that could derive benefit from immune checkpoint inhibitor therapy to tilt the balance in favor of the immune system.
引用
- Karn T, Jiang T, Hatzis C, et al. Association Between Genomic Metrics and Immune Infiltration in Triple-Negative Breast Cancer. JAMA Oncol. 2017. PMID: 28750120. doi:10.1001/jamaoncol.2017.2140
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。